Under the title “Holistic pro-Inflammatory Target for Sight (HITS)” the Ophthalmology Pivotal Meeting kicked off in Saudi ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story PhRMA warns ...

The MOU aims to collaborate on enhancing public health services, awareness programs, and advancing disease management ...

Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with ...

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D ... levels of government have created a supportive environment for the biopharmaceutical ...

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D ... a supportive environment for the biopharmaceutical industry, making Ontario a ...

With only about $1.6 billion in debt in December 2024 compared with $0.3 billion in cash and investments, Waters maintains a financially flexible balance sheet with net leverage around 1 time. Waters ...

We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its ...